| Row | Study Title | Conditions | Interventions | Detail |
|---|---|---|---|---|
| 169 | Master's Nursing Programs in Taiwan | Master's Nursing Programs |
: |
detail |
| 170 | To Assess the Influence of Aronox on Parameters Associated With Recovery Following Muscle Damaging Exercise | Muscle Damage |
Dietary Supplement:500mg of Aronox® >40% polyphenol aronia extract Other:Placebo |
detail |
| 171 | Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD | Posttraumatic Stress Disorder |
Behavioral:Compensatory Cognitive Training (CCT) Behavioral:Treatment as Usual (TAU) |
detail |
| 172 | Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma | Non-small Cell Lung Cancer Adenocarcinoma |
Drug:grapiprant and pembrolizumab |
detail |
| 173 | Randomized Controlled Trial for Ankle Fracture Pain Control | Ankle Fractures |
Drug:Long-Acting Local Anesthesia Drug:Regional Anesthesia |
detail |
| 174 | Selective Treatment According to Molecular Subtype of Prostate Cancer | Castration-resistant Prostate Cancer|Prostate Cancer Metastatic |
Drug:Luminal type-1 Drug:Luminal type-2 Drug:Neuroendocrine type-1 Drug:Neuroendocrine type-2 Drug:Atypical type-1 Drug:Atypical type-2 |
detail |
| 176 | The Late Presenter Treatment Optimisation Study | HIV/AIDS |
Drug:Biktarvy Drug:Symtuza |
detail |
| 177 | Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities | Mammographic Density |
Device:Magnetic resonance imaging |
detail |
| 178 | Investigating Musculoskeletal Health and Wellbeing | Musculoskeletal Pain, Frailty, Disability |
Other:questionnaire |
detail |
| 179 | Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage | Stroke, Acute |
Drug:Desmopressin Injection Drug:Normal saline |
detail |
京公网安备 11010102003638号